Pinned Tweet
📍
Fusing an anti-inflammatory enzyme indoleamine 2,3-dioxygenase to the tissue-anchoring protein galectin-3 ameliorates inflammation at the injection site while avoiding systemic immune suppression..
rdcu.be/dfpij [N&V]
rdcu.be/dfpip [Paper]
Benjamin Keselowsky retweeted
Link to the article published today @Nature, congrats to all @MJMitchell_Lab authors @a_hmltn @hannahsafford_ @HannahGeisler_ @ASThatte2 @rohan_palanki @AmandaMMurray14 @_emilyhan_ @Xuexiang_Han @ryannjoseph_ @AditiGhalsasi and @WeissmanLab @MgAlameh!
nature.com/articles/s41586-0…
Benjamin Keselowsky retweeted
Excited to share our latest in @Nature led by @SwingleKelsey on new mRNA LNP tech to treat life-threatening pregnancy disorders! Kelsey shows that LNPs engineered to deliver mRNA to the placenta can normalize vascular tissue to ameliorate pre-eclampsia:
blog.seas.upenn.edu/a-lipid-…
Benjamin Keselowsky retweeted
Congratulations to my @Rice_BIOE colleague Omid Veiseh @veiseho who is part of the 2024 @AcadofInventors Class of Fellows! Very deserving recognition for one of the most innovative researchers I know! Proud to be a fellow fellow, hope to be there for your induction! 🏅
We are proud to announce the Fellows Class of 2024!
This distinguished new class includes 170 exceptional inventors from over 135 research universities, governmental and non-profit research institutions worldwide.
Learn more about the Fellows Class of 2024: bit.ly/41wphZf
Benjamin Keselowsky retweeted
Wesley Hargrove presenting his work on encapsulating melphalan, a chemotherapeutic drug, in PLGA microspheres. @keselowsky #BMES2024
Benjamin Keselowsky retweeted
Jennifer Simonovich presenting her work on stable IDO mutants. @keselowsky @GregHudalla #BMES2024
Benjamin Keselowsky retweeted
Isabella Pinto presenting her work on Indoleamine 2,3-dioxygenase (IDO) functionalized hydrogel for suppression of inflammation. @GregHudalla @keselowsky #BMES2024
Benjamin Keselowsky retweeted
Ryan Clark presenting on combing microparticles and CATCH gels for sustained enzymatic reactions. @GregHudalla @keselowsky #BMES2024
Benjamin Keselowsky retweeted
Congratulations to Dr. Christine Schmidt, Distinguished Professor & J. Crayton Pruitt Family Endowed Chair, on being elected to @theNAMedicine – one of the highest honors bestowed upon scientists worldwide! @CESchmidt_UF news.ufl.edu/2024/10/nationa…
Benjamin Keselowsky retweeted
Just one month following her induction to the @theNAEng, @UFWertheim distinguished @UFBME professor, @CESchmidt_UF, is elected to @theNAMedicine — one of few recognized by both prestigious academies.
This accomplishment honors her groundbreaking research that has benefitted thousands and significantly advanced the fields of nerve regeneration and wound healing. ➡️ brnw.ch/UFnam
Benjamin Keselowsky retweeted
Thrilled to share our latest in Nature Reviews Drug Discovery @NatRevDrugDisc led by former Postdoc Ningqiang Gong (now Prof @USTCGlobal) in collaboration with @WeissmanLab on drug delivery technologies for generating cancer vaccines in situ!
Free access: rdcu.be/dMsLv
Benjamin Keselowsky retweeted
Our perspective in @natrevbioeng with this all-star team led by @jac_linnes & @WillitsLab is out! #BMEUNITE @SpringerNature Check it out (& RT + share!) to learn how your dept and others can contribute to diversifying our fields: rdcu.be/dH8lt
Benjamin Keselowsky retweeted
The official #WBC2024 after party - holding court on the 1s and 2s this Saturday in Itaewon
Benjamin Keselowsky retweeted
Congratulations to Dr. Benjamin Keselowsky who was elected a Fellow of Biomaterials Science and Engineering (FBSE) by the IUSBSE, the highest honor the global biomaterials community can bestow on outstanding scientists. @keselowsky #WBC2024
Benjamin Keselowsky retweeted
I’ll be dj’ing my personal favorite soul 45s at Living Room in Haebangchon 9:30-late on June 1. Anyone staying in Seoul after WBC should come through and get down.
Check it! Cool to see where fibronectin research is going. @Karin_Wang26
ADDR in press: Delivery technologies for therapeutic targeting of fibronectin fibrosis in autoimmunity and applications.
By Karin Wang & coworkers @templebioe
#fibronectin #autoimmunity
doi.org/10.1016/j.addr.2024.…
Benjamin Keselowsky retweeted
Thrilled to share our latest in Nature Communications @NatureComms led by @MJMitchell_Lab Postdoc @Lulu_Xuee on new cationic degradable lipid nanoparticles for antiangiogenic mRNA lung cancer therapy!
Study: nature.com/articles/s41467-0…
@Penn news story: blog.seas.upenn.edu/precisio…
Benjamin Keselowsky retweeted
Preeminent expert in the use of nanotechnology to understand and fight disease, Evan Scott, PhD, has been appointed director of the UVA Institute for Nanoscale Scientific and Technological Advanced Research, or nanoSTAR. @ProfScottBME @uvahealthnews @UVA news.med.virginia.edu/resear…
My heart was never in it anyway haha:
“Tweeting your research paper boosts engagement but not citations” nature.com/articles/d41586-0…



























